These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 30534690)
1. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy. Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
3. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency. Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy. Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116 [TBL] [Abstract][Full Text] [Related]
5. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
6. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
7. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504 [TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy. Jiang Y; Zhou Y; Zhang CY; Fang T Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132 [TBL] [Abstract][Full Text] [Related]
9. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. Banala VT; Urandur S; Sharma S; Sharma M; Shukla RP; Marwaha D; Gautam S; Dwivedi M; Mishra PR Biomater Sci; 2019 Jun; 7(7):2889-2906. PubMed ID: 31086900 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs. Yang M; Ding H; Zhu Y; Ge Y; Li L Colloids Surf B Biointerfaces; 2019 Mar; 175():126-135. PubMed ID: 30529818 [TBL] [Abstract][Full Text] [Related]
11. PEGylated hyperbranched polyphosphoester based nanocarriers for redox-responsive delivery of doxorubicin. Chen C; Zheng P; Cao Z; Ma Y; Li J; Qian H; Tao W; Yang X Biomater Sci; 2016 Mar; 4(3):412-7. PubMed ID: 26626655 [TBL] [Abstract][Full Text] [Related]
12. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. Yang X; Cai X; Yu A; Xi Y; Zhai G J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749 [TBL] [Abstract][Full Text] [Related]
13. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
15. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery. Huang D; Zhuang Y; Shen H; Yang F; Wang X; Wu D Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():60-68. PubMed ID: 29025675 [TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy. Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088 [TBL] [Abstract][Full Text] [Related]
17. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
18. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685 [TBL] [Abstract][Full Text] [Related]
19. Polymerizable disulfide paclitaxel prodrug for controlled drug delivery. Ding Y; Chen W; Hu J; Du M; Yang D Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():386-90. PubMed ID: 25280719 [TBL] [Abstract][Full Text] [Related]
20. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy. Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]